Fasikl Secures $10M in Series A Investment

(MINNEAPOLIS, Minn.) March 3, 2023 – Fasikl has closed a $10 million Series A equity investment to advance its AI-driven therapeutic technologies. The funding will support continued research and development and a pivotal clinical trial to pursue FDA clearance.